{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:59:09Z","timestamp":1774317549255,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972522"],"award-info":[{"award-number":["81972522"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Liaoning Provincial Department of Education Science and Technology Platform Construction Project","award":["LJ232410164004"],"award-info":[{"award-number":["LJ232410164004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-025-05969-2","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T18:23:11Z","timestamp":1763835791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ALKBH5 demethylation modification of SE-lncRNA ZMIZ1-AS1 promotes FGFR1-mediated proliferation and invasive metastasis in osteosarcoma"],"prefix":"10.1007","volume":"83","author":[{"given":"Yuanzhuang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeqiu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanjie","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongchao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0979-8835","authenticated-orcid":false,"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"issue":"Suppl 7","key":"5969_CR1","doi-asserted-by":"publisher","first-page":"vii320","DOI":"10.1093\/annonc\/mdq276","volume":"21","author":"J Ritter","year":"2010","unstructured":"Ritter J, Bielack SS (2010) Osteosarcoma. Ann Oncol 21(Suppl 7):vii320\u2013vii325","journal-title":"Ann Oncol"},{"issue":"8","key":"5969_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/01.JAA.0000541477.24116.8d","volume":"31","author":"E Simpson","year":"2018","unstructured":"Simpson E, Brown HL (2018) Understanding osteosarcomas. Jaapa 31(8):15\u201319","journal-title":"Jaapa"},{"issue":"6","key":"5969_CR3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s00335-021-09891-3","volume":"32","author":"Y Meng","year":"2021","unstructured":"Meng Y et al (2021) Circular RNA circNRIP1 plays oncogenic roles in the progression of osteosarcoma. Mamm Genome 32(6):448\u2013456","journal-title":"Mamm Genome"},{"issue":"4","key":"5969_CR4","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz D et al (2013) Super-enhancers in the control of cell identity and disease. Cell 155(4):934\u2013947","journal-title":"Cell"},{"issue":"2","key":"5969_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte WA et al (2013) Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153(2):307\u2013319","journal-title":"Cell"},{"issue":"2","key":"5969_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Lov\u00e9n","year":"2013","unstructured":"Lov\u00e9n J et al (2013) Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153(2):320\u2013334","journal-title":"Cell"},{"issue":"4","key":"5969_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ctrv.2013.11.006","volume":"40","author":"A Luetke","year":"2014","unstructured":"Luetke A et al (2014) Osteosarcoma treatment - where do we stand? A state of the art review. Cancer Treat Rev 40(4):523\u2013532","journal-title":"Cancer Treat Rev"},{"key":"5969_CR8","doi-asserted-by":"crossref","unstructured":"Chi Y et al (2019) Long Non-Coding RNA in the pathogenesis of cancers. Cells, 8(9)","DOI":"10.3390\/cells8091015"},{"issue":"1","key":"5969_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.molcel.2014.08.023","volume":"56","author":"K Schaukowitch","year":"2014","unstructured":"Schaukowitch K et al (2014) Enhancer RNA facilitates NELF release from immediate early genes. Mol Cell 56(1):29\u201342","journal-title":"Mol Cell"},{"issue":"11","key":"5969_CR10","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1261\/rna.061317.117","volume":"23","author":"B Soibam","year":"2017","unstructured":"Soibam B (2017) Super-lncrnas: identification of LncRNAs that target super-enhancers via RNA:DNA:DNA triplex formation. RNA 23(11):1729\u20131742","journal-title":"RNA"},{"issue":"1","key":"5969_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12943-020-01195-5","volume":"19","author":"Y Tan","year":"2020","unstructured":"Tan Y, Li Y, Tang F (2020) Oncogenic SeRNA functional activation: a novel mechanism of tumorigenesis. Mol Cancer 19(1):74","journal-title":"Mol Cancer"},{"key":"5969_CR12","doi-asserted-by":"publisher","first-page":"40644","DOI":"10.1038\/srep40644","volume":"7","author":"N Song","year":"2017","unstructured":"Song N et al (2017) Common risk variants for colorectal cancer: an evaluation of associations with age at cancer onset. Sci Rep 7:40644","journal-title":"Sci Rep"},{"issue":"5","key":"5969_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrg3724","volume":"15","author":"Y Fu","year":"2014","unstructured":"Fu Y et al (2014) Gene expression regulation mediated through reversible m\u2076A RNA methylation. Nat Rev Genet 15(5):293\u2013306","journal-title":"Nat Rev Genet"},{"issue":"1","key":"5969_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13045-022-01224-4","volume":"15","author":"J Qu","year":"2022","unstructured":"Qu J et al (2022) RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential. J Hematol Oncol 15(1):8","journal-title":"J Hematol Oncol"},{"key":"5969_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12935-020-01450-1","volume":"20","author":"J Wang","year":"2020","unstructured":"Wang J et al (2020) The biological function of m6A demethylase ALKBH5 and its role in human disease. Cancer Cell Int 20:347","journal-title":"Cancer Cell Int"},{"key":"5969_CR16","doi-asserted-by":"crossref","unstructured":"Han Y et al (2019) CVm6A: A visualization and exploration database for m\u2076As in cell lines. Cells 8(2)","DOI":"10.3390\/cells8020168"},{"key":"5969_CR17","doi-asserted-by":"publisher","first-page":"743990","DOI":"10.3389\/fonc.2021.743990","volume":"11","author":"Z Zhang","year":"2021","unstructured":"Zhang Z et al (2021) N6-Methyladenosine-Sculpted regulatory landscape of noncoding RNA. Front Oncol 11:743990","journal-title":"Front Oncol"},{"issue":"20","key":"5969_CR18","doi-asserted-by":"publisher","first-page":"11619","DOI":"10.1093\/nar\/gkac1027","volume":"50","author":"L Chen","year":"2022","unstructured":"Chen L et al (2022) METTL3-mediated m6A modification stabilizes TERRA and maintains telomere stability. Nucleic Acids Res 50(20):11619\u201311634","journal-title":"Nucleic Acids Res"},{"key":"5969_CR19","doi-asserted-by":"crossref","unstructured":"Sun Y et al (2025) LncRNA GAS5 regulates myometrial cell contractions in an m6A-Dependent manner. Function (Oxf) 6(2)","DOI":"10.1093\/function\/zqaf009"},{"issue":"7","key":"5969_CR20","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41419-022-05050-x","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang H et al (2022) m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression. Cell Death Dis 13(7):657","journal-title":"Cell Death Dis"},{"issue":"2","key":"5969_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L et al (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22(2):96\u2013118","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"5969_CR22","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1158\/1535-7163.MCT-14-0142","volume":"14","author":"H Takahashi","year":"2015","unstructured":"Takahashi H et al (2015) Significance of polypyrimidine tract-binding protein 1 expression in colorectal cancer. Mol Cancer Ther 14(7):1705\u20131716","journal-title":"Mol Cancer Ther"},{"issue":"15","key":"5969_CR23","doi-asserted-by":"publisher","first-page":"8776","DOI":"10.1073\/pnas.1432696100","volume":"100","author":"J Xie","year":"2003","unstructured":"Xie J et al (2003) Protein kinase A phosphorylation modulates transport of the polypyrimidine tract-binding protein. Proc Natl Acad Sci USA 100(15):8776\u20138781","journal-title":"Proc Natl Acad Sci USA"},{"key":"5969_CR24","doi-asserted-by":"publisher","first-page":"968458","DOI":"10.3389\/fmolb.2022.968458","volume":"9","author":"C Chen","year":"2022","unstructured":"Chen C et al (2022) PTBPs: an immunomodulatory-related prognostic biomarker in pan-cancer. Front Mol Biosci 9:968458","journal-title":"Front Mol Biosci"},{"issue":"9","key":"5969_CR25","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1111\/jcmm.15183","volume":"24","author":"C Cheng","year":"2020","unstructured":"Cheng C et al (2020) PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1. J Cell Mol Med 24(9):5274\u20135289","journal-title":"J Cell Mol Med"},{"issue":"2","key":"5969_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1631\/jzus.B1900422","volume":"21","author":"W Zhu","year":"2020","unstructured":"Zhu W et al (2020) Roles of PTBP1 in alternative splicing, glycolysis, and oncogensis. J Zhejiang Univ Sci B 21(2):122\u2013136","journal-title":"J Zhejiang Univ Sci B"},{"issue":"Pt 4","key":"5969_CR27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1042\/BST0360641","volume":"36","author":"K Sawicka","year":"2008","unstructured":"Sawicka K et al (2008) Polypyrimidine-tract-binding protein: a multifunctional RNA-binding protein. Biochem Soc Trans 36(Pt 4):641\u2013647","journal-title":"Biochem Soc Trans"},{"issue":"12","key":"5969_CR28","doi-asserted-by":"publisher","first-page":"10306","DOI":"10.1074\/jbc.M109686200","volume":"277","author":"B Li","year":"2002","unstructured":"Li B, Yen TS (2002) Characterization of the nuclear export signal of polypyrimidine tract-binding protein. J Biol Chem 277(12):10306\u201310314","journal-title":"J Biol Chem"},{"issue":"14","key":"5969_CR29","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1093\/nar\/20.14.3671","volume":"20","author":"A Ghetti","year":"1992","unstructured":"Ghetti A et al (1992) HnRNP I, the polypyrimidine tract-binding protein: distinct nuclear localization and association with HnRNAs. Nucleic Acids Res 20(14):3671\u20133678","journal-title":"Nucleic Acids Res"},{"key":"5969_CR30","doi-asserted-by":"publisher","first-page":"121512","DOI":"10.1016\/j.lfs.2023.121512","volume":"320","author":"Q Zhou","year":"2023","unstructured":"Zhou Q et al (2023) LncRNA HOXB-AS3 binding to PTBP1 protein regulates lipid metabolism by targeting SREBP1 in endometrioid carcinoma. Life Sci 320:121512","journal-title":"Life Sci"},{"issue":"2","key":"5969_CR31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41419-022-04509-1","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y et al (2022) LncRNA FIRRE functions as a tumor promoter by interaction with PTBP1 to stabilize BECN1 mRNA and facilitate autophagy. Cell Death Dis 13(2):98","journal-title":"Cell Death Dis"},{"issue":"15","key":"5969_CR32","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1158\/1078-0432.CCR-20-3905","volume":"27","author":"A Servetto","year":"2021","unstructured":"Servetto A et al (2021) Nuclear FGFR1 regulates gene transcription and promotes antiestrogen resistance in ER(+) breast cancer. Clin Cancer Res 27(15):4379\u20134396","journal-title":"Clin Cancer Res"},{"issue":"3","key":"5969_CR33","doi-asserted-by":"publisher","first-page":"744","DOI":"10.7150\/ijbs.74574","volume":"19","author":"Y Lin","year":"2023","unstructured":"Lin Y et al (2023) The FGFR1 signaling pathway upregulates the oncogenic transcription factor FOXQ1 to promote breast cancer cell growth. Int J Biol Sci 19(3):744\u2013759","journal-title":"Int J Biol Sci"},{"issue":"18","key":"5969_CR34","doi-asserted-by":"publisher","first-page":"e202424928","DOI":"10.1002\/anie.202424928","volume":"64","author":"H Wu","year":"2025","unstructured":"Wu H et al (2025) Discovery of covalent and Cell-Active ALKBH5 inhibitors with potent antileukemia effects in vivo. Angew Chem Int Ed Engl 64(18):e202424928","journal-title":"Angew Chem Int Ed Engl"},{"issue":"20","key":"5969_CR35","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1021\/jm2006222","volume":"54","author":"V Guagnano","year":"2011","unstructured":"Guagnano V et al (2011) Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase. J Med Chem 54(20):7066\u20137083","journal-title":"J Med Chem"},{"issue":"5","key":"5969_CR36","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1158\/1535-7163.MCT-12-0999","volume":"12","author":"GE Konecny","year":"2013","unstructured":"Konecny GE et al (2013) Activity of the fibroblast growth factor receptor inhibitors dovitinib (TKI258) and NVP-BGJ398 in human endometrial cancer cells. Mol Cancer Ther 12(5):632\u2013642","journal-title":"Mol Cancer Ther"},{"issue":"D1","key":"5969_CR37","doi-asserted-by":"publisher","first-page":"D1321","DOI":"10.1093\/nar\/gkaa698","volume":"49","author":"J Yang","year":"2021","unstructured":"Yang J et al (2021) PCAT: an integrated portal for genomic and preclinical testing data of pediatric cancer patient-derived xenograft models. Nucleic Acids Res 49(D1):D1321-d1327","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"5969_CR38","doi-asserted-by":"publisher","first-page":"D729","DOI":"10.1093\/nar\/gky1094","volume":"47","author":"R Zheng","year":"2019","unstructured":"Zheng R et al (2019) Cistrome data browser: expanded datasets and new tools for gene regulatory analysis. Nucleic Acids Res 47(D1):D729-d735","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"5969_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT et al (2011) Integrative genomics viewer. Nat Biotechnol 29(1):24\u201326","journal-title":"Nat Biotechnol"},{"issue":"4","key":"5969_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.trecan.2017.03.006","volume":"3","author":"S Sengupta","year":"2017","unstructured":"Sengupta S, George RE (2017) Super-enhancer-driven transcriptional dependencies in cancer. Trends Cancer 3(4):269\u2013281","journal-title":"Trends Cancer"},{"issue":"1","key":"5969_CR41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cell.2015.08.063","volume":"163","author":"Y Wang","year":"2015","unstructured":"Wang Y et al (2015) CDK7-dependent transcriptional addiction in triple-negative breast cancer. Cell 163(1):174\u2013186","journal-title":"Cell"},{"issue":"6","key":"5969_CR42","first-page":"506","volume":"41","author":"HY Shin","year":"2018","unstructured":"Shin HY (2018) Targeting super-enhancers for disease treatment and diagnosis. Mol Cells 41(6):506\u2013514","journal-title":"Mol Cells"},{"issue":"10","key":"5969_CR43","doi-asserted-by":"publisher","first-page":"113163","DOI":"10.1016\/j.celrep.2023.113163","volume":"42","author":"Y Gao","year":"2023","unstructured":"Gao Y et al (2023) ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m(6)A modification-mediated RNA stability control. Cell Rep 42(10):113163","journal-title":"Cell Rep"},{"issue":"6","key":"5969_CR44","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41423-021-00680-1","volume":"18","author":"B Liu","year":"2021","unstructured":"Liu B et al (2021) Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m(6)A demethylation of Nr4a1 mRNA. Cell Mol Immunol 18(6):1412\u20131424","journal-title":"Cell Mol Immunol"},{"issue":"Database issue","key":"5969_CR45","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH et al (2014) StarBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 42(Database issue):D92\u2013D97","journal-title":"Nucleic Acids Res"},{"key":"5969_CR46","doi-asserted-by":"crossref","unstructured":"Armaos A et al (2021) CatRAPID omics v2.0: going deeper and wider in the prediction of protein-RNA interactions. 49W1:pW72\u2013w79","DOI":"10.1093\/nar\/gkab393"},{"issue":"20","key":"5969_CR47","doi-asserted-by":"publisher","first-page":"11626","DOI":"10.1093\/nar\/gkaa814","volume":"48","author":"N Toki","year":"2020","unstructured":"Toki N et al (2020) Sineup long non-coding RNA acts via PTBP1 and HNRNPK to promote translational initiation assemblies. Nucleic Acids Res 48(20):11626\u201311644","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"5969_CR48","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/cam4.268","volume":"3","author":"M Fernanda Amary","year":"2014","unstructured":"Fernanda Amary M et al (2014) Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy. Cancer Med 3(4):980\u2013987","journal-title":"Cancer Med"},{"key":"5969_CR49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12943-015-0391-4","volume":"14","author":"L Ling","year":"2015","unstructured":"Ling L et al (2015) Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy. Mol Cancer 14:136","journal-title":"Mol Cancer"},{"issue":"22","key":"5969_CR50","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1038\/onc.2015.344","volume":"35","author":"D Weekes","year":"2016","unstructured":"Weekes D et al (2016) Regulation of osteosarcoma cell lung metastasis by the c-Fos\/AP-1 target FGFR1. Oncogene 35(22):2852\u20132861","journal-title":"Oncogene"},{"issue":"1","key":"5969_CR51","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13045-022-01331-2","volume":"15","author":"T Zhang","year":"2022","unstructured":"Zhang T et al (2022) Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-\u03b2\/SMAD3 pathway. J Hematol Oncol 15(1):114","journal-title":"J Hematol Oncol"},{"issue":"1","key":"5969_CR52","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s13046-021-02129-9","volume":"40","author":"E Bian","year":"2021","unstructured":"Bian E et al (2021) Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc. J Exp Clin Cancer Res 40(1):337","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"5969_CR53","doi-asserted-by":"publisher","first-page":"e2204711","DOI":"10.1002\/advs.202204711","volume":"10","author":"JY Peng","year":"2022","unstructured":"Peng JY et al (2022) Upregulation of Superenhancer-Driven LncRNA FASRL by USF1 promotes de Novo fatty acid biosynthesis to exacerbate hepatocellular carcinoma. Adv Sci (Weinh) 10(1):e2204711","journal-title":"Adv Sci (Weinh)"},{"issue":"14","key":"5969_CR54","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.1073\/pnas.0601222103","volume":"103","author":"K Kakumoto","year":"2006","unstructured":"Kakumoto K et al (2006) FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts. Proc Natl Acad Sci USA 103(14):5490\u20135495","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"5969_CR55","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1158\/0008-5472.CAN-04-1911","volume":"65","author":"CB Pollock","year":"2005","unstructured":"Pollock CB et al (2005) Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells. Cancer Res 65(4):1244\u20131250","journal-title":"Cancer Res"},{"issue":"1","key":"5969_CR56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","volume":"13","author":"C Zeng","year":"2020","unstructured":"Zeng C et al (2020) Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol 13(1):117","journal-title":"J Hematol Oncol"},{"key":"5969_CR57","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fonc.2019.00251","volume":"9","author":"Z Ianniello","year":"2019","unstructured":"Ianniello Z, Paiardini A, Fatica A (2019) N(6)-Methyladenosine (m(6)A): A promising new molecular target in acute myeloid leukemia. Front Oncol 9:251","journal-title":"Front Oncol"},{"issue":"1","key":"5969_CR58","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40364-020-00244-x","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X et al (2020) N6-methyladenine modification in noncoding RNAs and its function in cancer. Biomark Res 8(1):61","journal-title":"Biomark Res"},{"key":"5969_CR59","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12935-020-1105-6","volume":"20","author":"S Chen","year":"2020","unstructured":"Chen S, Zhou L, Wang Y (2020) ALKBH5-mediated m(6)A demethylation of LncRNA PVT1 plays an oncogenic role in osteosarcoma. Cancer Cell Int 20:34","journal-title":"Cancer Cell Int"},{"key":"5969_CR60","doi-asserted-by":"publisher","first-page":"104019","DOI":"10.1016\/j.ebiom.2022.104019","volume":"80","author":"Z Yang","year":"2022","unstructured":"Yang Z et al (2022) ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner. EBioMedicine 80:104019","journal-title":"EBioMedicine"},{"issue":"9","key":"5969_CR61","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41588-020-0644-z","volume":"52","author":"Z Zhang","year":"2020","unstructured":"Zhang Z et al (2020) Genetic analyses support the contribution of mRNA N(6)-methyladenosine (m(6)A) modification to human disease heritability. Nat Genet 52(9):939\u2013949","journal-title":"Nat Genet"},{"issue":"1","key":"5969_CR62","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1006\/excr.1997.3677","volume":"235","author":"MG Romanelli","year":"1997","unstructured":"Romanelli MG et al (1997) Sequence determinants for HnRNP I protein nuclear localization. Exp Cell Res 235(1):300\u2013304","journal-title":"Exp Cell Res"},{"issue":"3","key":"5969_CR63","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1097-2765(00)80345-7","volume":"4","author":"CA Cote","year":"1999","unstructured":"Cote CA et al (1999) A xenopus protein related to HnRNP I has a role in cytoplasmic RNA localization. Mol Cell 4(3):431\u2013437","journal-title":"Mol Cell"},{"issue":"5","key":"5969_CR64","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.molcel.2014.04.025","volume":"54","author":"N Dimitrova","year":"2014","unstructured":"Dimitrova N et al (2014) LincRNA-p21 activates p21 in cis to promote polycomb target gene expression and to enforce the G1\/S checkpoint. Mol Cell 54(5):777\u2013790","journal-title":"Mol Cell"},{"issue":"7","key":"5969_CR65","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1093\/nar\/gkv1353","volume":"44","author":"J Huang","year":"2016","unstructured":"Huang J et al (2016) Linc-RoR promotes c-Myc expression through HnRNP I and AUF1. Nucleic Acids Res 44(7):3059\u20133069","journal-title":"Nucleic Acids Res"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05969-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05969-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05969-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:17:26Z","timestamp":1768472246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05969-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5969"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05969-2","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"19 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}